Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

Nasdaq Bears Dig In: Short Interest Hits Record 18.38 Billion Shares Amid Valuation Anxiety

December 24, 2025

As the final trading days of 2025 approach, the Nasdaq has reached a staggering milestone that has both bulls and bears on edge. According to the latest settlement data released on December 15, 2025,...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Hims & Hers Hit A GLP-1 Speed Bump This Year — But Growth Is Just Cooling, Not Cracking ↗

December 24, 2025

Hims & Hers has drawn scrutiny for selling compounded GLP-1 treatments – lower-cost, unapproved alternatives to blockbuster weight-loss drugs made by Eli Lilly and Novo Nordisk.

Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.

3 Profitable Stocks for Long-Term Investors

December 23, 2025

Amazon and Hims & Hers look like good picks for 2026.

2 Top Stocks to Buy With $500 Right Now ↗

December 19, 2025

These are three stocks I am looking to buy.

Topics Artificial Intelligence Economy Stocks

3 Stocks High on My Watch List to Buy ↗

December 17, 2025

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,...

1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 That Underwhelm

December 15, 2025

Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and...

1 Stock Under $50 with Exciting Potential and 2 We Brush Off

December 11, 2025

5 High Short-Interest Stocks to Buy Before Q1 2026 ↗

December 09, 2025

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

2 Cash-Producing Stocks to Keep an Eye On and 1 That Underwhelm

December 04, 2025

The healthcare industry is ripe for disruption.

Why Is Hims & Hers Stock Falling, and Should Investors Buy the Dip? ↗

November 26, 2025

Retail Traders Crown Novo Nordisk As Long-Term Weight Loss King — Even As Eli Lilly Hits $1T And Viking Fans Tout ‘M&A Prize’ ↗

November 25, 2025

Users pointed to emerging drug pipelines, GLP-1 expansion and rising M&A pressure across the sector.

Hims, Block, and NRG Just Launched Huge Stock Buybacks ↗

November 24, 2025

Alignment Healthcare, Hims & Hers Health, Surgery Partners, Guardant Health, and Pediatrix Medical Group Stocks Trade Up, What You Need To Know

November 24, 2025

A number of stocks jumped in the afternoon session after a Politico report revealed that the White House plans to pitch a two-year extension of Obamacare subsidies. The proposal would extend subsidies...

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small...

Topics Economy

1 Small-Cap Stock with Exciting Potential and 2 We Avoid

November 23, 2025

MarketBeat Week in Review – 11/17 - 11/21 ↗

November 22, 2025

A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining...

2 Cash-Heavy Stocks with Competitive Advantages and 1 We Find Risky

November 21, 2025

KeyCorp Delivers Sobering Outlook for LifeMD, Slashing Price Target Amidst Operational Headwinds

November 20, 2025

KeyCorp, through its KeyBanc capital markets division, has issued a significantly more pessimistic forecast for LifeMD (NASDAQ: LFMD) stock, dramatically lowering its price objective to $8.00 from a...

Via MarketMinute

HIMS Has Been a Roller Coaster Ride. Should Investors Hop On? ↗

November 19, 2025

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 4.9% in the afternoon session after news of increased competition in the weight-loss drug market overshadowed the company’s own positive...

Ready For A Rebound? Here Are 10 Oversold Stocks To Watch ↗

November 17, 2025

Via Benzinga

Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today

November 17, 2025

Shares of Hims & Hers are trading marginally lower Monday morning, as competitive news overshadows bullish announcements from the company.

What's Going On With Hims & Hers Health Shares Monday? ↗

November 17, 2025

Via Benzinga

Hims & Hers Announces New $250 Million Share Repurchase Program – Retail Sees A Steady Trading Range For The Stock ↗

November 17, 2025

The latest buyback program follows a $100 million share buyback program in July 2024, which has now been completed.

Hims & Hers launches Labs, offering annual biomarker testing plans with doctor-developed guidance and expanded diagnostics planned across key health categories.

Hims & Hers Introduces Labs With Annual Plans For Comprehensive Testing ↗

November 14, 2025

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

November 14, 2025

Via Benzinga

1 Healthcare Stock to Consider Right Now and 2 Facing Headwinds

November 13, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and...

Hims & Hers Stock Logs 3-Day Losing Streak As Truist Calls Out Klarna GLP-1 Changes — Retail Sees Fresh Buy Zone ↗

Topics Stocks

November 13, 2025

Truist pointed to updated GLP-1 intake features, including Klarna financing, shorter shipping intervals and new semaglutide microdosing options.

Lucid, Avis, Hims & Hers Health and Upstart are some of the most heavily shorted stocks right now. Here's a look at the top ten.

Looking For A Squeeze? Here Are The Top 10 Most Shorted Stocks ↗

November 13, 2025

Via Benzinga

2 Strong Healthcare Stock Picks for Growth Investors ↗

November 13, 2025

If you're a growth-oriented stock buyer, there are plenty of options in the healthcare space.